ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,509.01
      0.62%
      US Tech 100
      19,460.00
      0.95%
      Dow Jones
      39,331.85
      0.41%
      Brent Oil
      86.26
      -0.21%
      Bitcoin
      62,117.76
      0.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Solventum Corporation (SOLV) Quote

      Solventum Corporation

      Solventum Corporation (SOLV)

      SolVBL Solutions Inc
      Solvac SA
      51.60
      0.15
      (0.29%)
      Closed July 02 4:00PM
      Delayed by 15 minutes
      51.60
      0.00
      (0.00%)
      After Hours: 4:15PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      51.60
      Bid
      -
      Ask
      -
      Volume
      1,309,794
      51.20 Day's Range 51.83
      50.49 52 Week Range 72.40
      Market Cap
      8.912B
      Previous Close
      51.45
      Open
      51.20
      Last Trade
      202300
      @
      51.6
      Last Trade Time
      Financial Volume
      $ 67,499,161
      VWAP
      51.5342
      Average Volume (3m)
      1,966,334
      Shares Outstanding
      172,709,505
      Dividend Yield
      -
      PE Ratio
      12.88
      Earnings Per Share (EPS)
      4.01
      Revenue
      8.24B
      Net Profit
      692M

      About Solventum Corporation

      Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symboliz... Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.solventum.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Solventum Corporation is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker SOLV. The last closing price for Solventum was $51.45. Over the last year, Solventum shares have traded in a share price range of $ 50.49 to $ 72.40.

      Solventum currently has 172,709,505 shares outstanding. The market capitalization of Solventum is $8.91 billion. Solventum has a price to earnings ratio (PE ratio) of 12.88.

      SOLV Latest News

      More News

      U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings

      U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings PR Newswire ST. PAUL...

      11 hours ago
      PR Newswire (US)

      FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth

      13 hours ago

      Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue

      Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue PR Newswire ST. PAUL, Minn., June 24, 2024...

      June 24 2024
      PR Newswire (US)

      Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

      Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer" PR Newswire ST. PAUL, Minn., June 7, 2024 ST. PAUL, Minn., June 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV...

      June 07 2024
      PR Newswire (US)

      Form 8-K - Current report

      May 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 15 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 15 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 15 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 15 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.360.70257611241251.2453.5650.49143821051.22069508CS
      4-5.25-9.2348284960456.8557.2850.49192863153.60571751CS
      12-14.26-21.651989067765.866850.49196633459.8483121CS
      26-17.55-25.379609544569.1572.450.49245577961.98388344CS
      52-17.55-25.379609544569.1572.450.49245577961.98388344CS
      156-17.55-25.379609544569.1572.450.49245577961.98388344CS
      260-17.55-25.379609544569.1572.450.49245577961.98388344CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RDZNRoadzen Inc
      $ 2.95
      (82.10%)
      		107.94M
      SYTSYLA Technologies Company Ltd
      $ 3.05
      (59.69%)
      		6.18M
      VSVersus Systems Inc
      $ 1.90
      (43.94%)
      		58.91M
      VIVKVivakor Inc
      $ 3.41
      (36.95%)
      		727.46k
      MEDSTRxADE HEALTH Inc
      $ 18.585
      (30.70%)
      		397.65k
      MAXNMaxeon Solar Technologies Ltd
      $ 0.18
      (-67.20%)
      		173.66M
      RNACCartesian Therapeutics Inc
      $ 15.7715
      (-35.02%)
      		1.45M
      EFTReFFECTOR Therapeutics Inc
      $ 0.18
      (-32.56%)
      		1.62M
      DTSSDatasea Inc
      $ 3.43
      (-30.57%)
      		1.15M
      ARDXArdelyx Inc
      $ 5.29
      (-30.12%)
      		22.66M
      NVDANVIDIA Corporation
      $ 122.67
      (-1.31%)
      		220.28M
      TSLATesla Inc
      $ 231.26
      (10.20%)
      		204.95M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.18
      (-67.20%)
      		173.66M
      SQQQProShares UltraPro Short QQQ
      $ 7.88
      (-2.96%)
      		114.49M
      RDZNRoadzen Inc
      $ 2.95
      (82.10%)
      		107.94M

      SOLV Discussion

      View Posts
      DewDiligence DewDiligence 3 days ago
      SOLV 1Q24 Results by Business Segment
      %Corp YoY Growth
      Segment Sales (const currency)
      Medical/surgical* 56% flat
      Dental 17% flat
      Health-info systems 16% flat
      Purification/filtration 12% +7% *Includes components for other companies’ medical devices.
      👍️0
      DewDiligence DewDiligence 3 days ago
      SOLV’s “AI play”—>heath-information systems segment:

      https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

      Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
      👍️0
      KingOfSwing...Trading KingOfSwing...Trading 1 month ago
      Thank for the excellent post. Very useful.
      👍️0
      DewDiligence DewDiligence 2 months ago
      SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:

      https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html

      SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.

      SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)

      The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.

      p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
      👍️0
      Porgie Tirebiter Porgie Tirebiter 3 months ago
      All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.

      I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
      👍️0
      DewDiligence DewDiligence 3 months ago
      SOLV begins trading on NYSE following completion of spinoff from 3M:

      https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
      👍️ 1
      DewDiligence DewDiligence 3 months ago
      SOLV Investor Day CC slides:

      https://d1io3yog0oux5.cloudfront.net/_7984eceea22d0dd69e55aae6e648ee7c/3m/db/3194/30840/presentation/Solventum+Investor+Day+3.19.2024.pdf
      👍️ 1
      DewDiligence DewDiligence 3 months ago
      SOLV issues 2024 guidance:

      https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html

      • Organic revenue growth of -2% to 0%

      • Adjusted earnings per share (EPS) of $6.10 to $6.40

      • Free cash flow of $700M to $800M
      👍️ 1
      DewDiligence DewDiligence 4 months ago
      Details of 3M’s SOLV spinoff finalized:

      https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html

      3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.

      This is a tax-exempt distribution for US residents.
      👍️0
      DewDiligence DewDiligence 4 months ago
      SOLV sells $6.9B of debt in six tranches:

      • $1B of 3yr notes @5.45%

      • $1.5B of 5yr notes @5.40%

      • $1B of 7yr notes @5.45%

      • $1.65B of 10yr notes @5.60%

      • $1.25B of 30yr notes @5.90%

      • $0.5B of 40yr notes @6.00%

      The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.

      All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
      👍️ 1
      DewDiligence DewDiligence 4 months ago
      SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
      👍️0
      DewDiligence DewDiligence 4 months ago
      These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:

      https://engage.3m.com/purification

      https://www.3m.com/3M/en_US/health-information-systems-us/

      https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)

      https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)

      https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
      👍️0
      DewDiligence DewDiligence 4 months ago
      Further details of 3M/SOLV capitalization:

      SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)

      After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
      👍️0
      DewDiligence DewDiligence 4 months ago
      3M sets 4/1/24 date for Solventum spin-off:

      https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
      👍️0

      Your Recent History

      NYSE
      SOLV
      Solventum
      Delayed Upgrade Clock